Aligos Therapeutics, Inc.
ALGS
$10.17
$0.303.04%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 32.27% | 30.05% | 22.28% | -58.04% | 6.38% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -11.45% | -0.70% | 0.36% | -3.31% | 16.28% |
| Total Current Assets | 29.58% | 28.50% | 21.29% | -55.95% | 6.94% |
|
|
|||||
| Total Current Assets | 29.58% | 28.50% | 21.29% | -55.95% | 6.94% |
| Net Property, Plant & Equipment | -29.53% | -28.90% | -25.52% | -25.38% | -24.72% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 12.28% | 1.43% | 1.12% | 0.32% | 1.93% |
| Total Assets | 24.13% | 23.80% | 17.82% | -53.74% | 3.00% |
|
|
|||||
| Total Accounts Payable | 69.74% | -42.26% | 56.93% | 2.15% | -6.83% |
| Total Accrued Expenses | -3.93% | 1.20% | -8.65% | -7.63% | 14.92% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.79% | 5.51% | 6.51% | 6.76% | 4.45% |
| Total Finance Division Other Current Liabilities | -74.35% | -56.33% | -- | -88.46% | -83.42% |
| Total Other Current Liabilities | -74.35% | -56.33% | -- | -88.46% | -83.42% |
| Total Current Liabilities | 4.92% | -14.00% | 0.36% | -9.07% | -6.73% |
|
|
|||||
| Total Current Liabilities | 4.92% | -14.00% | 0.36% | -9.07% | -6.73% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -56.36% | -48.50% | -39.16% | -37.75% | -32.69% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.47% | -19.93% | -74.01% | 161.97% | 25,206.52% |
| Total Liabilities | -1.04% | -21.02% | -49.70% | 66.65% | 23.52% |
|
|
|||||
| Common Stock & APIC | 18.50% | 18.67% | 18.92% | 1.77% | 14.06% |
| Retained Earnings | -16.14% | -14.36% | -10.21% | -26.95% | -16.77% |
| Treasury Stock & Other | -21.14% | -14.98% | -6.09% | -17.25% | 16.10% |
| Total Common Equity | 43.39% | 51.52% | 94.74% | -131.47% | -8.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 43.39% | 51.52% | 94.74% | -131.47% | -8.62% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 43.39% | 51.52% | 94.74% | -131.47% | -8.62% |
|
|
|||||